How much does a box of molnupiravir capsules cost?

Molnupiravir capsules (Molnupiravir) are antiviral drugs used to treat COVID-19, a coronavirus disease caused by the new coronavirus (SARS-CoV-2). Monolavir capsules were originally produced by Merck and Ridgeback in the United States. Biotherapeutics developed it and submitted it to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) in 2021. The mechanism of action of monogravir capsules is to reduce the symptoms and spread of COVID-19 by inhibiting the replication of the virus.

Monoravir Capsules are already on the market in China, but are not yet included in medical insurance. Please consult your local hospital pharmacy for specific prices. The cheaper ones abroad are Indian generic drugs, which cost around three to four hundred yuan, and the ingredients of domestic original drugs and foreign generic drugs are basically the same.

Research on monogravir capsules shows that it can reduce the risk of hospitalization and death in patients with early exposure to the virus. The special feature of this drug is that it is an oral formulation, so it can be conveniently used at home and does not require hospitalization.

It should be noted that the safety and effectiveness of drugs are still being continuously evaluated in research, especially as different virus variants emerge. If you or someone you know has COVID-19 or has symptoms, you should consult a medical professional, follow medical advice, and understand the latest guidance from your local health department. Medication should be supervised and administered by a physician.